Broadlane undergoes executive shakeup

Jeff Byers | | Health Imaging | Artificial Intelligence

Healthcare Management provider Broadlane has announced that the company's board chairman Patrick T. Ryan will assume the CEO position. Also, Thomas Sherry, Broadlane’s chief operating officer will become president.

David C. Ricker, president and CEO of the Dallas-based company, has elected to step down from his full-time role, but he will continue as a member of the board of directors. “As a founder of the company, I have achieved many of my goals over the past 10 years,” said Ricker.

Prior to joining Broadlane, Ryan served as CEO of Polymedica until its successful sale to Medco Health Solutions in 2007. In addition, Ryan is a member of the boards of directors of Affiliated Managers Group and Infusion Resources.

Jeff Byers

Related Content

FDA has now approved more than 1,000 clinical AI applications, most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%
Clinicians want AI to show its work
ACR Assess-AI national data registry tracks performance of clinical algorithms
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.